The new EU vaccine probe delves into Europe’s coveted problems


The deployment of stuttering vaccines in Europe faced several hurdles on Friday as EU regulators said they were reviewing the side effects of the Johnson & Johnson shooting and France further limited the use of the AstraZeneca puncture.

The U.S. drug regulator said it had found no “causal” link between the J&J vaccine and blood clots, but that its investigation was continuing after “some people” suffered complications.

Much of the world is still in the clutches of the pandemic that has killed 2.9 million people, from Brazil, where the virus kills more than 4,000 people a day, to Japan, where the government has tightened restrictions once month.

In India, the most affected state of Maharashtra is running out of vaccines as the health system bends under the weight of the contagion. Instead of the megacity of Bombay, Maharashtra has been placed under a curfew and weekend closures.

And across Europe, populations are facing some of the toughest antivirus measures in the world, even though the epidemic refuses to slow it down.

All of France is subject to restrictions in some way, and so far the country has dealt blows to more than 10 million people.

But he has repeatedly changed the rules on the AstraZeneca vaccine, first out of doubt about its effectiveness, then out of fear that it could be related to blood clots.

He did so again on Friday, and Health Minister Olivier Veran said citizens under the age of 55 who had received a first vaccine with AstraZeneca would receive a different vaccine for their second dose.

But shortly after speaking, the World Health Organization said there was no “adequate data” to support switching Covid-19 vaccines between doses.

As Europe continues to roll in constant ranks over the AstraZeneca spike, the EU drug regulator announced it would study a second time for concerns about blood clots.

The European Medicines Agency (EMA) said four “serious cases” of unusual blood clots, one of them fatal, had been reported with the Johnson & Johnson vaccine, which uses technology similar to AstraZeneca. .

The U.S. Drug and Food Administration said it has not yet found any “causal” link between the pad and the clots.

But he noted that “some people” in the country had clots and low levels of platelets in their blood after receiving the vaccine, and their research continued.

“Both conditions can have many different causes,” the agency said.

Johnson & Johnson issued a statement saying the company was aware that “thromboembolic events have been reported … with all Covid-19 vaccines.”

But the statement added: “At present, no clear causal relationship has been established between these rare events and the Janssen COVID-19 vaccine,” referring to the European subsidiary of J&J.

Both funnels are approved for use in the European Union, but the J&J vaccine has not yet been rolled out and several EU countries have stopped or limited the use of AstraZeneca.

The supply problem also makes it difficult to deploy vaccines.

India, which is one of the world’s leading vaccine manufacturers, is suffering its own problems with the coups in Maharashtra, home to more than 100 million people and the economic center of Mumbai.

“Most Bombay hospitals will run out of supplies by the end of the day,” Mangala Gomare, who oversees the city’s vaccination program, told AFP on Friday.

In the United States, Johnson & Johnson vaccine deliveries will drop sharply next week, U.S. health officials warned Friday.

Meanwhile, Pfizer-BioNTech requested authorization to use the Covid-19 vaccine in children aged 12 to 15 in the US.

The companies said in a statement that they plan to make similar requests from other regulators around the world in the coming days.

In Europe, an AstraZeneca spokesman said half of its vaccine shipments to the EU will be delayed this week.

Swedish climate advocate Greta Thunberg said on Friday she would omit an upcoming climate meeting in Britain because countries could not participate on equal terms.

“With the distribution of vaccines extremely unfair, I will not attend the COP26 conference if development continues as it is now,” Thunberg told AFP.

Illustrating its point, so far Britain has given at least one blow to more than 31 million people, almost half of its population, compared to poorer countries like Mexico, which has administered less than 10 million blows. to only seven percent of its population.

The central government of Germany has tried to defeat the virus through restrictions on movement and trade, but several states have torpedoed the strategy by refusing to follow the proposals.

Now Berlin is changing the rules to bring together a more centralized power.

The proposed adjustments are likely to trigger night curfews and some school closures in particularly affected areas.

Japan has also tightened measures in the capital Tokyo and other areas, mainly calling for the early closure of bars.

On the other hand, Italy will have to end the blocking measures from next week for Lombardy, the epicenter of its coronavirus pandemic, and several other regions with improved contagion statistics.

And in Brazil, the Senate said it will open an investigation into the government’s management of the coronavirus pandemic, as President Jair Bolsonaro continues to resist blocking measures, even with deaths from Covid-19 according to new records.

However, Rio de Janeiro on Friday reversed the restrictions in force for two weeks, reopening restaurants and bars, although the city’s famous beaches remained closed.

Source link